Suppr超能文献

一种基于人群的方法来确定分子放射治疗中的时间积分活度。

A population-based method to determine the time-integrated activity in molecular radiotherapy.

作者信息

Hardiansyah Deni, Riana Ade, Kletting Peter, Zaid Nouran R R, Eiber Matthias, Pawiro Supriyanto A, Beer Ambros J, Glatting Gerhard

机构信息

Medical Physics and Biophysics Division, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, 16424, Depok, Indonesia.

Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

出版信息

EJNMMI Phys. 2021 Dec 14;8(1):82. doi: 10.1186/s40658-021-00427-x.

Abstract

BACKGROUND

The calculation of time-integrated activities (TIAs) for tumours and organs is required for dosimetry in molecular radiotherapy. The accuracy of the calculated TIAs is highly dependent on the chosen fit function. Selection of an adequate function is therefore of high importance. However, model (i.e. function) selection works more accurately when more biokinetic data are available than are usually obtained in a single patient. In this retrospective analysis, we therefore developed a method for population-based model selection that can be used for the determination of individual time-integrated activities (TIAs). The method is demonstrated at an example of [Lu]Lu-PSMA-I&T kidneys biokinetics. It is based on population fitting and is specifically advantageous for cases with a low number of available biokinetic data per patient.

METHODS

Renal biokinetics of [Lu]Lu-PSMA-I&T from thirteen patients with metastatic castration-resistant prostate cancer acquired by planar imaging were used. Twenty exponential functions were derived from various parameterizations of mono- and bi-exponential functions. The parameters of the functions were fitted (with different combinations of shared and individual parameters) to the biokinetic data of all patients. The goodness of fits were assumed as acceptable based on visual inspection of the fitted curves and coefficients of variation CVs < 50%. The Akaike weight (based on the corrected Akaike Information Criterion) was used to select the fit function most supported by the data from the set of functions with acceptable goodness of fit.

RESULTS

The function [Formula: see text] with shared parameter [Formula: see text] was selected as the function most supported by the data with an Akaike weight of 97%. Parameters [Formula: see text] and [Formula: see text] were fitted individually for every patient while parameter [Formula: see text] was fitted as a shared parameter in the population yielding a value of 0.9632 ± 0.0037.

CONCLUSIONS

The presented population-based model selection allows for a higher number of parameters of investigated fit functions which leads to better fits. It also reduces the uncertainty of the obtained Akaike weights and the selected best fit function based on them. The use of the population-determined shared parameter for future patients allows the fitting of more appropriate functions also for patients for whom only a low number of individual data are available.

摘要

背景

分子放射治疗剂量测定需要计算肿瘤和器官的时间积分活度(TIA)。计算得到的TIA的准确性高度依赖于所选的拟合函数。因此,选择合适的函数非常重要。然而,当有比单个患者通常获得的更多生物动力学数据时,模型(即函数)选择的工作会更准确。因此,在这项回顾性分析中,我们开发了一种基于群体的模型选择方法,可用于确定个体时间积分活度(TIA)。该方法以[镥]镥-PSMA-I&T肾脏生物动力学为例进行了演示。它基于群体拟合,对于每个患者可用生物动力学数据数量较少的情况特别有利。

方法

使用通过平面成像获得的13例转移性去势抵抗性前列腺癌患者的[镥]镥-PSMA-I&T肾脏生物动力学数据。从单指数和双指数函数的各种参数化中导出了20个指数函数。将这些函数的参数(具有共享参数和个体参数的不同组合)拟合到所有患者的生物动力学数据上。基于对拟合曲线的目视检查和变异系数CVs<50%,认为拟合优度是可接受的。使用Akaike权重(基于校正后的Akaike信息准则)从拟合优度可接受的函数集中选择数据最支持的拟合函数。

结果

具有共享参数[公式:见正文]的函数[公式:见正文]被选为数据最支持的函数,Akaike权重为97%。每个患者的参数[公式:见正文]和[公式:见正文]单独拟合,而参数[公式:见正文]作为群体中的共享参数拟合,得到的值为0.9632±0.0037。

结论

所提出的基于群体的模型选择允许研究的拟合函数有更多参数,从而导致更好的拟合。它还降低了获得的Akaike权重和基于它们选择的最佳拟合函数的不确定性。将群体确定的共享参数用于未来患者,也允许为仅有少量个体数据的患者拟合更合适的函数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a273/8671591/f71b0bec08e6/40658_2021_427_Fig1_HTML.jpg

相似文献

1
A population-based method to determine the time-integrated activity in molecular radiotherapy.
EJNMMI Phys. 2021 Dec 14;8(1):82. doi: 10.1186/s40658-021-00427-x.
2
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.
Z Med Phys. 2024 Aug;34(3):419-427. doi: 10.1016/j.zemedi.2023.01.007. Epub 2023 Feb 20.
5
Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.
Nucl Med Mol Imaging. 2024 May;58(3):120-128. doi: 10.1007/s13139-024-00851-8. Epub 2024 Feb 23.
7
Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51. doi: 10.1007/s00259-015-3174-7. Epub 2015 Aug 29.
8
Particle filter de-noising of voxel-specific time-activity-curves in personalized Lu therapy.
Z Med Phys. 2020 May;30(2):116-134. doi: 10.1016/j.zemedi.2019.10.005. Epub 2019 Dec 17.
10

引用本文的文献

4
Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.
Nucl Med Mol Imaging. 2024 May;58(3):120-128. doi: 10.1007/s13139-024-00851-8. Epub 2024 Feb 23.
5
Metabolic kinetic modeling of [C]methionine based on total-body PET in multiple myeloma.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2683-2691. doi: 10.1007/s00259-023-06219-y. Epub 2023 Apr 11.
7
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.
Z Med Phys. 2024 Aug;34(3):419-427. doi: 10.1016/j.zemedi.2023.01.007. Epub 2023 Feb 20.
10
Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
Z Med Phys. 2023 Feb;33(1):70-81. doi: 10.1016/j.zemedi.2022.06.004. Epub 2022 Aug 10.

本文引用的文献

3
Modeling and Predicting Tumor Response in Radioligand Therapy.
J Nucl Med. 2019 Jan;60(1):65-70. doi: 10.2967/jnumed.118.210377. Epub 2018 May 10.
4
The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for Lu-Labeled PSMA Peptides.
J Nucl Med. 2018 Jun;59(6):929-933. doi: 10.2967/jnumed.117.203505. Epub 2018 Feb 1.
5
Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule.
EJNMMI Res. 2016 Dec;6(1):30. doi: 10.1186/s13550-016-0185-8. Epub 2016 Mar 25.
6
The role of patient-based treatment planning in peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging. 2016 May;43(5):871-880. doi: 10.1007/s00259-015-3248-6. Epub 2015 Nov 18.
7
The NUKDOS software for treatment planning in molecular radiotherapy.
Z Med Phys. 2015 Sep;25(3):264-74. doi: 10.1016/j.zemedi.2015.01.001. Epub 2015 Mar 17.
9
Treatment planning in molecular radiotherapy.
Z Med Phys. 2013 Dec;23(4):262-9. doi: 10.1016/j.zemedi.2013.03.005. Epub 2013 Apr 15.
10
Nuclear medicine dosimetry: quantitative imaging and dose calculations.
Z Med Phys. 2011 Dec;21(4):246-7. doi: 10.1016/j.zemedi.2011.07.005. Epub 2011 Sep 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验